ArticleAnnals of translational medicine2021

FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis.

Lu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.